Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.64
+0.37 (5.09%)
At close: Aug 13, 2025, 4:00 PM
7.65
+0.01 (0.13%)
Pre-market: Aug 14, 2025, 8:30 AM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $451.33 million as of August 14, 2025. Its market cap has decreased by -59.53% in one year.
Market Cap
451.33M
Enterprise Value
187.37M
1-Year Change
-59.53%
Ranking
Category
Stock Price
$7.64
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $451.33M, a decrease of -45.59%. That is a compound annual growth rate of -12.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 451.33M | -36.36% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |